Journal article
Pharmacotherapy for social anxiety disorder: an update.
Abstract
Since the emergence of social phobia into the diagnostic nomenclature, we have seen an exponential expansion in our knowledge regarding effective treatment of this disorder. The literature clearly supports the use of SSRIs and the SNRI venlafaxine ER as first line pharmacological agents in the treatment of GSAD. In this article, treatment studies of pharmacotherapy of social phobia are summarized. Additional issues such as comparative efficacy, …
Authors
Van Ameringen M; Mancini C; Patterson B; Simpson W
Journal
Israel journal of psychiatry and related sciences, Vol. 46, No. 1, pp. 53–61
Publication Date
2009
ISSN
0333-7308
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AnticonvulsantsAntidepressive Agents, Second-GenerationAntipsychotic AgentsBenzodiazepinesCyclohexanolsDrug ResistanceHumansMonoamine Oxidase InhibitorsPhobic DisordersPsychotropic DrugsRandomized Controlled Trials as TopicSecondary PreventionSelective Serotonin Reuptake InhibitorsVenlafaxine Hydrochloride